Cargando…

Surgical Treatment of Vulvar HSIL: Adjuvant HPV Vaccine Reduces Recurrent Disease

Data suggest that adjuvant human papillomavirus (HPV)-vaccination in women treated for cervical HPV diseases reduces recurrent disease. This study investigates adjuvant HPV-vaccination and the rate of recurrence in women undergoing surgery for vulvar high-grade squamous intraepithelial lesions (HSIL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghelardi, Alessandro, Marrai, Roberto, Bogani, Giorgio, Sopracordevole, Francesco, Bay, Paola, Tonetti, Arianna, Lombardi, Stefania, Bertacca, Gloria, Joura, Elmar A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911252/ https://www.ncbi.nlm.nih.gov/pubmed/33503866 http://dx.doi.org/10.3390/vaccines9020083

Ejemplares similares

HPV prevalence in vulvar cancer in Austria
por: Pils, Sophie, et al.
Publicado: (2017)

The re-infection rate of high-risk HPV and the recurrence rate of vulvar intraepithelial neoplasia (VIN) usual type after surgical treatment
por: Frega, Antonio, et al.
Publicado: (2011)

Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL
por: Bhuyan, Prakash K., et al.
Publicado: (2020)

Multiple Human Papilloma Virus (HPV) Infections Are Associated with HSIL and Persistent HPV Infection Status in Korean Patients
por: Kim, Moonsik, et al.
Publicado: (2021)

Limitations on the Detection Rate of High-Risk HPV by Hybrid Capture 2 Methodology in High Grade Intraepithelial (HSIL) or Atypical Squamous Cells-Cannot Exclude HSIL (ASC-H) Cytological Lesions with Proved CIN2+
por: Noël, Jean-Christophe, et al.
Publicado: (2015)

Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data
por: Joura, Elmar A, et al.
Publicado: (2012)

HPV16 viral characteristics in primary, recurrent and metastatic vulvar carcinoma
por: Lillsunde Larsson, Gabriella, et al.
Publicado: (2018)

Additional role of ECC in the detection and treatment of cervical HSIL
por: Sijing, Li, et al.
Publicado: (2023)

Effectiveness of the Quadrivalent HPV Vaccine in Preventing Anal ≥ HSILs in a Spanish Population of HIV+ MSM Aged > 26 Years
por: Hidalgo-Tenorio, Carmen, et al.
Publicado: (2021)

Usefulness of E7 mRNA in HPV16-Positive Women to Predict the Risk of Progression to HSIL/CIN2+
por: Martí, Cristina, et al.
Publicado: (2021)

Prevalence and risk factors associated with high-grade anal squamous intraepithelial lesions (HSIL)-AIN2 and HSIL-AIN3 in homosexual men
por: Machalek, Dorothy A., et al.
Publicado: (2016)

Adjuvant HPV Vaccination to Prevent Recurrent Cervical Dysplasia after Surgical Treatment: A Meta-Analysis
por: Di Donato, Violante, et al.
Publicado: (2021)

Platelet-to-Lymphocyte Ratio (PLR) as the Prognostic Factor for Recurrence/Residual Disease in HSIL Patients After LEEP
por: Huang, Guanxiang, et al.
Publicado: (2023)

Cytological, Colposcopic and Pathohistological Correlation of HSIL and ASC H Findings
por: Jahic, Mahira, et al.
Publicado: (2020)

Role of Low-Risk HPV PCR Monoinfection in Screening for HSIL and Anal Cancer in Men Who Have Sex with Men Living with HIV
por: García-Martínez, Carmen María, et al.
Publicado: (2023)

HPV-associated vulvar carcinoma with sebaceous differentiation
por: Kuan, Irena, et al.
Publicado: (2023)

The impact of p16(ink4a) positivity in invasive vulvar cancer on disease-free and disease-specific survival, a retrospective study
por: Gensthaler, Lisa, et al.
Publicado: (2020)

Effectiveness of Prophylactic Human Papillomavirus Vaccine in the Prevention of Recurrence in Women Conized for HSIL/CIN 2-3: The VENUS Study
por: Casajuana-Pérez, Andrea, et al.
Publicado: (2022)

Pre-operative hypoalbuminemia is associated with complication rate and overall survival in patients with vulvar cancer undergoing surgery
por: Bekos, Christine, et al.
Publicado: (2019)

The value of Ki67 for the diagnosis of LSIL and the problems of p16 in the diagnosis of HSIL
por: Liu, Jixuan, et al.
Publicado: (2022)

Laser CO(2) treatment for vulvar lymphedema secondary to gynecological cancer therapy: A report of two cases and review of the literature
por: SOPRACORDEVOLE, FRANCESCO, et al.
Publicado: (2015)

Outcome of vulvar reconstruction in patients with advanced and recurrent vulvar malignancies
por: Zhang, Wei, et al.
Publicado: (2015)

The risk factors of residual lesions and recurrence of the high-grade cervical intraepithelial lesions (HSIL) patients with positive-margin after conization
por: Chen, Jun-yu, et al.
Publicado: (2018)

Efficacy of HPV Vaccination Regarding Vulvar and Vaginal Recurrences in Previously Treated Women: The Need for Further Evidence
por: Bechini, Angela, et al.
Publicado: (2023)

Colposcopic Impression Has a Key Role in the Estimation of the Risk of HSIL/CIN3
por: del Pino, Marta, et al.
Publicado: (2021)

Is Primary HPV with Secondary p16/Ki67 Dual-Stain an Alternative HSIL-Risk Detection Strategy in Cervical Cancer Screening for Women under 30 Years?
por: Trzeszcz, Martyna, et al.
Publicado: (2021)

Myths and fake messages about human papillomavirus (HPV) vaccination: answers from the ESGO Prevention Committee
por: Taumberger, Nadja, et al.
Publicado: (2022)

HPV screening in the urine of transpeople - A prevalence study
por: Pils, Sophie, et al.
Publicado: (2022)

A Very Rare Case: HPV-Negative Vulvar Cancer in an Adolescent
por: Kahramanoglu, Ilker, et al.
Publicado: (2018)

What do women with gynecologic cancer know about HPV and their individual disease? A pilot study
por: Pils, Sophie, et al.
Publicado: (2014)

Decreased Ovarian Reserve Predicts Inexplicability of Recurrent Miscarriage? A Retrospective Analysis
por: Pils, Sophie, et al.
Publicado: (2016)

The Diagnostic Utility of p16 Immunostaining in Differentiating Cancer and HSIL from LSIL and Benign in Cervical Cells
por: Wu, Ming-Zhe, et al.
Publicado: (2018)

Diagnostic Three Slides Pap Test Compared to Punch Biopsy and Endocervical Curettage in Confirmed HSIL+ Diagnosis
por: Rubeša-Mihaljević, Roberta, et al.
Publicado: (2021)

Should the management of high grade cervical squamous intraepithelial lesion (HSIL) be different in HIV-positive women?
por: Gilles, Christine, et al.
Publicado: (2021)

In Situ/Microinvasive Adenocarcinoma of the Uterine Cervix and HPV-Type Impact: Pathologic Features, Treatment Options, and Follow-Up Outcomes—Cervical Adenocarcinoma Study Group (CAS-Group)
por: Giannella, Luca, et al.
Publicado: (2023)

Recurrence of vulvar carcinoma: A multidisciplinary approach
por: Rei, M., et al.
Publicado: (2019)

Epithelial-mesenchymal transition-like events in vulvar cancer and its relation with HPV
por: Rodrigues, I S, et al.
Publicado: (2013)

HSIL-Based Synthesis of Ultracrystalline K,Na-JBW, a Zeolite Exhibiting Exceptional Framework Ordering and Flexibility
por: Asselman, Karel, et al.
Publicado: (2022)

Early Age at First Sexual Intercourse is Associated with Higher Prevalence of High-grade Squamous Intraepithelial Lesions (HSIL)
por: Xavier-Júnior, José Cândido Caldeira, et al.
Publicado: (2017)

Extramammary Paget’s Disease of the Vulva and Concomitant Premalignant/Malignant Vulvar Lesions: A Potential Challenge in Diagnosis and Treatment
por: Clemente, Nicolò, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bf0lb7jf03sh7hn1hmne7mhb77